{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:59:35Z","timestamp":1791305975042,"version":"4.3.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T00:00:00Z","timestamp":1390780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T00:00:00Z","timestamp":1390780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,1,22]]},"DOI":"10.1038\/onc.2013.571","type":"journal-article","created":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T13:40:17Z","timestamp":1390830017000},"page":"445-454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Oncogenic Y641 mutations in EZH2 prevent Jak2\/\u03b2-TrCP-mediated degradation"],"prefix":"10.1038","volume":"34","author":[{"given":"A A","family":"Sahasrabuddhe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Velusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S J","family":"Elenitoba-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,27]]},"reference":[{"key":"BFonc2013571_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/fon.10.157","volume":"7","author":"A Piunti","year":"2011","unstructured":"Piunti A, Pasini D . Epigenetic factors in cancer development: polycomb group proteins. Fut Oncol 2011; 7: 57\u201375.","journal-title":"Fut Oncol"},{"key":"BFonc2013571_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nrc2931","volume":"10","author":"AA Mills","year":"2010","unstructured":"Mills AA . Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nat Rev Cancer 2010; 10: 669\u2013682.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2013571_CR3","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1242\/dev.00625","volume":"130","author":"S Erhardt","year":"2003","unstructured":"Erhardt S, Su IH, Schneider R, Barton S, Bannister AJ, Perez-Burgos L et al. Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development. Development 2003; 130: 4235\u20134248.","journal-title":"Development"},{"key":"BFonc2013571_CR4","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1182\/blood-2010-05-267096","volume":"116","author":"D Martin-Perez","year":"2010","unstructured":"Martin-Perez D, Piris MA, Sanchez-Beato M . Polycomb proteins in hematologic malignancies. Blood 2010; 116: 5465\u20135475.","journal-title":"Blood"},{"key":"BFonc2013571_CR5","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1038\/cddis.2011.84","volume":"2","author":"H Richly","year":"2011","unstructured":"Richly H, Aloia L, Di Croce L . Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis 2011; 2: e204.","journal-title":"Cell Death Dis"},{"key":"BFonc2013571_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.stem.2010.08.002","volume":"7","author":"M Sauvageau","year":"2010","unstructured":"Sauvageau M, Sauvageau G . Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 2010; 7: 299\u2013313.","journal-title":"Cell Stem Cell"},{"key":"BFonc2013571_CR7","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1038\/sj.emboj.7600402","volume":"23","author":"D Pasini","year":"2004","unstructured":"Pasini D, Bracken AP, Jensen MR, Lazzerini Denchi E, Helin K . Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 2004; 23: 4061\u20134071.","journal-title":"EMBO J"},{"key":"BFonc2013571_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron R, Reinberg D . The polycomb complex PRC2 and its mark in life. Nature 2011; 469: 343\u2013349.","journal-title":"Nature"},{"key":"BFonc2013571_CR9","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.molcel.2013.02.013","volume":"49","author":"JA Simon","year":"2013","unstructured":"Simon JA, Kingston RE . Occupying chromatin: Polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol Cell 2013; 49: 808\u2013824.","journal-title":"Mol Cell"},{"key":"BFonc2013571_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrm2763","volume":"10","author":"JA Simon","year":"2009","unstructured":"Simon JA, Kingston RE . Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 2009; 10: 697\u2013708.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2013571_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.stem.2010.08.004","volume":"7","author":"LE Surface","year":"2010","unstructured":"Surface LE, Thornton SR, Boyer LA . Polycomb group proteins set the stage for early lineage commitment. Cell Stem Cell 2010; 7: 288\u2013298.","journal-title":"Cell Stem Cell"},{"key":"BFonc2013571_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 2010; 42: 181\u2013185.","journal-title":"Nat Genet"},{"key":"BFonc2013571_CR13","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1182\/blood-2013-04-496893","volume":"122","author":"C Bodor","year":"2013","unstructured":"Bodor C, Grossmann V, Popov N, Okosun J, O'Riain C, Tan K et al. EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood 2013; 122: 3165\u20133168.","journal-title":"Blood"},{"key":"BFonc2013571_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","volume":"23","author":"W Beguelin","year":"2013","unstructured":"Beguelin W, Popovic R, Teater M, Jiang Y, Bunting KL, Rosen M et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 2013; 23: 677\u2013692.","journal-title":"Cancer Cell"},{"key":"BFonc2013571_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature11606","volume":"492","author":"MT McCabe","year":"2012","unstructured":"McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 2012; 492: 108\u2013112.","journal-title":"Nature"},{"key":"BFonc2013571_CR16","doi-asserted-by":"publisher","first-page":"7922","DOI":"10.1073\/pnas.1303800110","volume":"110","author":"SK Knutson","year":"2013","unstructured":"Knutson SK, Warholic NM, Wigle TJ, Klaus CR, Allain CJ, Raimondi A et al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc Natl Acad Sci USA 2013; 110: 7922\u20137927.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013571_CR17","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nchembio.1084","volume":"8","author":"SK Knutson","year":"2012","unstructured":"Knutson SK, Wigle TJ, Warholic NM, Sneeringer CJ, Allain CJ, Klaus CR et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol 2012; 8: 890\u2013896.","journal-title":"Nat Chem Biol"},{"key":"BFonc2013571_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/2040620712466864","volume":"4","author":"R Popovic","year":"2013","unstructured":"Popovic R, Shah MY, Licht JD . Epigenetic therapy of hematological malignancies: where are we now? Ther Adv Hematol 2013; 4: 81\u201391.","journal-title":"Ther Adv Hematol"},{"key":"BFonc2013571_CR19","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.4161\/cc.10.8.15372","volume":"10","author":"AA Sahasrabuddhe","year":"2011","unstructured":"Sahasrabuddhe AA, Dimri M, Bommi PV, Dimri GP . betaTrCP regulates BMI1 protein turnover via ubiquitination and degradation. Cell Cycle 2011; 10: 1322\u20131330.","journal-title":"Cell Cycle"},{"key":"BFonc2013571_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bbrc.2011.04.025","volume":"408","author":"M Zoabi","year":"2011","unstructured":"Zoabi M, Sadeh R, de Bie P, Marquez VE, Ciechanover A . PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins. Biochem Biophys Res Commun 2011; 408: 393\u2013398.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2013571_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/emmm.201201783","volume":"5","author":"YL Yu","year":"2013","unstructured":"Yu YL, Chou RH, Shyu WC, Hsieh SC, Wu CS, Chiang SY et al. Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke. EMBO Mol Med 2013; 5: 531\u2013547.","journal-title":"EMBO Mol Med"},{"key":"BFonc2013571_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm1547","volume":"6","author":"MD Petroski","year":"2005","unstructured":"Petroski MD, Deshaies RJ . Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6: 9\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2013571_CR23","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1128\/MCB.01191-12","volume":"33","author":"H Chen","year":"2013","unstructured":"Chen H, Ma H, Inuzuka H, Diao J, Lan F, Shi YG et al. DNA damage regulates UHRF1 stability via the SCF(beta-TrCP) E3 ligase. Mol Cell Biol 2013; 33: 1139\u20131148.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013571_CR24","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1128\/MCB.05746-11","volume":"31","author":"MK Tan","year":"2011","unstructured":"Tan MK, Lim HJ, Harper JW . SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation. Mol Cell Biol 2011; 31: 3687\u20133699.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013571_CR25","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1101\/gad.1574507","volume":"21","author":"H Liu","year":"2007","unstructured":"Liu H, Cheng EH, Hsieh JJ . Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions. Genes Dev 2007; 21: 2385\u20132398.","journal-title":"Genes Dev"},{"key":"BFonc2013571_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/carcin\/bgp305","volume":"31","author":"M Dimri","year":"2010","unstructured":"Dimri M, Bommi PV, Sahasrabuddhe AA, Khandekar JD, Dimri GP . Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis 2010; 31: 489\u2013495.","journal-title":"Carcinogenesis"},{"key":"BFonc2013571_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cell.2011.09.019","volume":"147","author":"MJ Emanuele","year":"2011","unstructured":"Emanuele MJ, Elia AE, Xu Q, Thoma CR, Izhar L, Leng Y et al. Global identification of modular cullin-RING ligase substrates. Cell 2011; 147: 459\u2013474.","journal-title":"Cell"},{"key":"BFonc2013571_CR28","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nature07884","volume":"458","author":"TA Soucy","year":"2009","unstructured":"Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Adhikari S et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 2009; 458: 732\u2013736.","journal-title":"Nature"},{"key":"BFonc2013571_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrc2396","volume":"8","author":"D Frescas","year":"2008","unstructured":"Frescas D, Pagano M . Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 2008; 8: 438\u2013449.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2013571_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrc1881","volume":"6","author":"KI Nakayama","year":"2006","unstructured":"Nakayama KI, Nakayama K . Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006; 6: 369\u2013381.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2013571_CR31","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S1097-2765(03)00234-X","volume":"11","author":"G Wu","year":"2003","unstructured":"Wu G, Xu G, Schulman BA, Jeffrey PD, Harper JW, Pavletich NP . Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Mol Cell 2003; 11: 1445\u20131456.","journal-title":"Mol Cell"},{"key":"BFonc2013571_CR32","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1101\/gad.1983810","volume":"24","author":"S Kaneko","year":"2010","unstructured":"Kaneko S, Li G, Son J, Xu CF, Margueron R, Neubert TA et al. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev 2010; 24: 2615\u20132620.","journal-title":"Genes Dev"},{"key":"BFonc2013571_CR33","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1128\/MCB.24.11.4955-4967.2004","volume":"24","author":"LS Argetsinger","year":"2004","unstructured":"Argetsinger LS, Kouadio JL, Steen H, Stensballe A, Jensen ON, Carter-Su C . Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity. Mol Cell Biol 2004; 24: 4955\u20134967.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013571_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1101\/gad.1499407","volume":"21","author":"Y Kotake","year":"2007","unstructured":"Kotake Y, Cao R, Viatour P, Sage J, Zhang Y, Xiong Y . pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev 2007; 21: 49\u201354.","journal-title":"Genes Dev"},{"key":"BFonc2013571_CR35","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1182\/blood-2010-04-280149","volume":"116","author":"I Velichutina","year":"2010","unstructured":"Velichutina I, Shaknovich R, Geng H, Johnson NA, Gascoyne RD, Melnick AM et al. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood 2010; 116: 5247\u20135255.","journal-title":"Blood"},{"key":"BFonc2013571_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.tibs.2010.02.009","volume":"35","author":"L Morey","year":"2010","unstructured":"Morey L, Helin K . Polycomb group protein-mediated repression of transcription. Trends Biochem Sci 2010; 35: 323\u2013332.","journal-title":"Trends Biochem Sci"},{"key":"BFonc2013571_CR37","doi-asserted-by":"publisher","first-page":"e00005","DOI":"10.7554\/eLife.00005","volume":"1","author":"C Ciferri","year":"2012","unstructured":"Ciferri C, Lander GC, Maiolica A, Herzog F, Aebersold R, Nogales E . Molecular architecture of human polycomb repressive complex 2. Elife 2012; 1: e00005.","journal-title":"Elife"},{"key":"BFonc2013571_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1476-4598-9-158","volume":"9","author":"AK Yadav","year":"2010","unstructured":"Yadav AK, Sahasrabuddhe AA, Dimri M, Bommi PV, Sainger R, Dimri GP . Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain. Mol Cancer 2010; 9: 158.","journal-title":"Mol Cancer"},{"key":"BFonc2013571_CR39","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1073\/pnas.1214326110","volume":"110","author":"T Velusamy","year":"2013","unstructured":"Velusamy T, Palanisamy N, Kalyana-Sundaram S, Sahasrabuddhe AA, Maher CA, Robinson DR et al. Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2013; 110: 3035\u20133040.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2013571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013571","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:18:53Z","timestamp":1647890333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2013571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,27]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,1,22]]}},"alternative-id":["BFonc2013571"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.571","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,27]]},"assertion":[{"value":"22 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}